Final results from a pivotal, multicenter, international, open-label, phase 2 study of romidepsin in progressive or relapsed peripheral T-cell lymphoma (PTCL) following prior systemic therapy

収録刊行物

• 52nd American Society of Hematology Annual Meeting and Exposition Abstract 114 Orange County Convention Center, Orlando, FL, USA, 2010

  52nd American Society of Hematology Annual Meeting and Exposition Abstract 114 Orange County Convention Center, Orlando, FL, USA, 2010 2010